Future perspectives of If inhibition in various cardiac conditions

European Heart Journal, Supplement

Volumn 7, Issue H, 2005, Pages

  Fox, Kim ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Congestive heart failure; Coronary artery disease; Heart rate; If inhibition; Ivabradine; Sinus node inhibitor

Indexed keywords

ANTIANGINA PECTORIS AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; IVABRADINE;

ANGIOCARDIOGRAPHY; ATHEROSCLEROSIS; BRADYCARDIA; CLINICAL TRIAL; CORRELATION ANALYSIS; HEART INFARCTION; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MORBIDITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINUS NODE;

EID: 24744457768     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/sui051     Document Type: Review

References (24)

1. Hjalmarson Å. Significance of reduction of heart rate in cardiovascular disease. Clin Cardiol 1998;21:II3-II7.
2. Benetos A, Rudnichi A, Thomas F et al. Influence of heart rate on mortality in a French population: role of age, gender and blood pressure. Hypertension 1999;33:44-52.
3. Dyer AR, Persky V, Stamler J et al. Heart rate as a prognostic factor for coronary heart disease and mortality. Findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-749.
4. Kannel WB, Kannel C, Paffenbarger RS Jr et al. Heart rate and cardiovascular mortality. The Framingham Study. Am Heart J 1987;113:1489-1494.
5. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991;121:172-177.
6. Kjekshus J. Importance of heart-rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
7. Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999;1(Suppl. H):H64-H69.
8. Guth BD, Heusch G, Seitelberger R et al. Mechanism of beneficial effect of beta-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987;60:738-746.
9. Simonsen S, Ihlen H, Kjekshus JK. Haemodynamic and metabolic effects of timolol (Blocadren) on ischaemic myocardium. Acta Med Scand 1983;213:393-398.
10. Colin P, Ghaleh B, Monnet X et al. Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 2004,308:236-240.
11. Simon L, Ghaleh B, Puyssabet L et al. Coronary and haemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-666.
12. f inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology 2003;100:149-155.
13. Kovar D, Cannon CP, Bentley JH et al. Does initial and delayed heart rate predict mortality in patients with acute coronary syndromes? Clin Cardiol 2004;27:80-86.
14. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on coronary atherosclerosis. Science 1984;226:180-182.
15. Perski A, Olsson G, Landou C et al. Minimum heart rate and coronary atherosclerosis; independent relations to global severity and rate of progression of angiographic lesions in men with myocardial infarction at a young age. Am Heart J 1992;123:609-616.
16. Patel S, Breall J, Diver D et al. Bradycardia is associated with development of coronary collateral vessels in humans. Coron Artery Dis 2000;11:467-471.
17. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate associated with coronary plaque disruption. Circulation 2001;104:1477-1482.
18. Sa Cunha R, Pannier B, Benetos A et al. Association between high heart rate and high arterial rigidity in normotensive and hypertensive subjects. J Hypertens 1997;15:1423-1430.
19. Kjekshus J, Gullestad L. Heart rate as a therapeutic target in heart failure. Eur Heart J 1999;1(Suppl. H):H64-H69.
20. Lechat P, Hulot JS, Escolano S et al. Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II trial. Circulation 2001;103:1428-1433.
21. MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: metoptolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999;353:9-13.
22. f current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004;109:1674-1679.
23. Jondeau G, Korewicki J, Vasiliauskas D. Effect of ivabradine in patients with left ventricular systolic dysfunction and coronary artery disease. Eur Heart J 2004;25(Suppl. 2637):451.
24. Yusuf S, Camm J. Sinus tachyarrhythmia and the specific bradycardic agents: a marriage made in heaven? J Cardiovasc Pharmacol Therapeut 2004;8:89-105.